Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.78669 | 33 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.73579 | 32 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.74264 | 33 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.65558 | 31 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.69955 | 33 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.78212 | 31 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.80953 | 33 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.71133 | 32 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.71 | 32 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.72386 | 32 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.7206 | 32 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.7217 | 33 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.73021 | 32 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.73166 | 32 |